Evotec logo

Evotec

Europe, Hamburg, Germany, Hamburg

Description

Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.

Investor Profile

Evotec has made 27 investments, with 1 in the past 12 months and 19% as lead.

Stage Focus

  • Series A (37%)
  • Series B (22%)
  • Series C (11%)
  • Seed (11%)
  • Series Unknown (7%)
  • Corporate Round (4%)
  • Post Ipo Equity (4%)
  • Pre Seed (4%)

Country Focus

  • United States (33%)
  • Germany (22%)
  • United Kingdom (22%)
  • Ireland (7%)
  • France (7%)
  • Spain (4%)
  • Italy (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Artificial Intelligence (Ai)
  • Medical
  • Oncology
  • Genetics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Evotec frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
GT Healthcare Capital Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 3
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 2
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 2
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2

What are some of recent deals done by Evotec?

Aptadir Therapeutics

Milan, Lombardia, Italy

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

BiotechnologyHealth CareMedical
Pre SeedSep 24, 2024
Amount Raised: $1,600,000
Aeovian Pharmaceuticals

San Francisco, California, United States

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AMar 28, 2024
Amount Raised: $50,000,000
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMar 14, 2024
Amount Raised: $139,300,472
Carrick Therapeutics

Dublin, Dublin, Ireland

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CDec 1, 2022
Amount Raised: $60,000,000
Cajal Neuroscience

Seattle, Washington, United States

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

BiotechnologyNeurosciencePharmaceuticalTherapeutics
Series ANov 29, 2022
Amount Raised: $96,000,000
Tubulis

Munich, Bayern, Germany

Tubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series BMay 3, 2022
Amount Raised: $63,152,643
Centauri Therapeutics

Sandwich, Kent, United Kingdom

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series AFeb 16, 2022
Amount Raised: $32,596,295
IMIDomics

Barcelona, Catalonia, Spain

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

BiotechnologyHealth Care
Corporate RoundFeb 15, 2022
Immunitas Therapeutics

Cambridge, Massachusetts, United States

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series BAug 18, 2021
Amount Raised: $58,000,000
Topas Therapeutics

Hamburg, Hamburg, Germany

A biotechnology company focused on developing products to address areas of major unmet need.

Advanced MaterialsBiotechnologyChemicalChemical Engineering
Series BJul 29, 2021
Amount Raised: $21,404,695